Latest:

Fat Pitch Financials

Special situation stocks and value investing

Stock Quote

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Ark Genomic Revolution ETF (NY: ARKG )

31.63 -0.09 (-0.28%)
Official Closing Price Updated: 8:00 PM EDT, May 31, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,960,097
Open 31.51
Bid (Size) 31.48 (48)
Ask (Size) 31.78 (1)
Prev. Close 31.72
Today's Range 31.02 - 32.18
52wk Range 26.38 - 43.88
Shares Outstanding 645,500
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Did Cathie Wood's Innovation ARKK ETF Whiff On AI? How It Compares To FAANG, Nvidia In 2023
One of the most recognizable investing names of the last decade is Ark Funds CEO Cathie Wood. With an eye on high-growth stocks and innovation, the Ark Funds outperformed the market for years during... 
Via Benzinga
Cathie Wood Loads Up On Biotech Stocks — Continues To Raise Stake In Coinbase Global
 
Via Benzinga

Performance

YTD
+14.56%
+14.56%
1 Month
+8.32%
+8.32%
3 Month
+4.22%
+4.22%
6 Month
+3.67%
+3.67%
1 Year
-1.95%
-1.95%

More News

Read More
Cathie Wood Trims Stake In This Chinese E-Commerce Giant – Loads Up On Butterfly Network Stock
Via Benzinga
Move Over, ChatGPT: 5 Stock Ideas For Leveraging The Power Of AI In Health Care, Cybersecurity
Via Benzinga
10 Best Stocks to Buy in March 2023
Via The Motley Fool
Cathie Wood Makes Biggest Coinbase Purchase Of Year After Earnings Beat
Via Investor's Business Daily
3 Cathie Wood Stocks That Could More Than Double in 12 Months, According to Wall Street
Via The Motley Fool
When Small Cap Biotechs Lose Momentum: Are You An Investor Or A Trader?
Via Talk Markets
Cathie Wood Trims Robinhood Stake As Stock Gains 28% In January — Also Offloads Shares In This Biotech Company
Via Benzinga
Why Teladoc Stock Popped 5% Today
Via The Motley Fool
Healthcare Sector Is Lagging As We Enter 2022 Earnings Season
Via Talk Markets
Don't Call It A Comeback: Cathie Wood Is Beating The S&P 500 In Early 2023
Via Benzinga
J.P.Morgan Healthcare Conference JPM23: Biotech Rally Favors Smaller Caps
Via Talk Markets
Cathie Wood Makes This Molecular Diagnostics Company Top Holding Of Ark Invest's Flagship Fund, Catapulting Past Zoom, Tesla
Via Benzinga
Cathie Wood Gets Elon Musk's Attention Over Gene-Editing Therapy Potential: 'Investors Chased The Dream Then. Now, They're Running Away'
Via Benzinga
War, Inflation, Fed Hawkishness, Elon Musk's Twitter Buy: How These Factors Weighed On Cathie Wood's Top Holdings In 2022
Via Benzinga
Precious Metals Outperformed Stocks And Bonds In 2022
Via Talk Markets
2 Cathie Wood Stocks to Buy and Hold Through 2023 and Beyond
Via The Motley Fool
'Study The Mindset Of Stonk Hodlers': This Fund Manager Rips Cathie Wood's Investment Strategy
Via Benzinga
Cathie Wood Adds $7M Of This Clinical-Stage Biotech, Trims Stake In CVS-Target Signify Health
Via Benzinga
Getting Ready For The Coming Stock Market Elevator Drop
Via Talk Markets
This Congressman Just Purchased 2 Stocks Which Consistently Increase Dividends
Via Benzinga
Cathie Wood Has Bet Big On These 10 Stocks; Here's How They're Performing
Via Investor's Business Daily
Cathie Wood Is Selling This High-Flying Stock. Here's Why You Should Buy It Instead
Via The Motley Fool
Cathie Wood Increases Stake In 4 Stocks By Over 1,000% - Plus 4 New Holdings For Ark
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.